ABBOTT LABORATORIES
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
$325,369 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Common shares without par value
VICE PRESIDENT AND CONTROLLER
Common shares without par value
VICE PRESIDENT AND CONTROLLER
Common shares without par value
EVP AND CFO
Common shares without par value
CHAIRMAN AND CEO
Common shares without par value
CHAIRMAN AND CEO
Common shares without par value
CHAIRMAN AND CEO
Common shares without par value
CHAIRMAN AND CEO
Common shares without par value
CHAIRMAN AND CEO
Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CHAIRMAN AND CEO
Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EXECUTIVE VICE PRESIDENT
Common shares without par value
EXECUTIVE VICE PRESIDENT
Common shares without par value
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
Director
Stock Equivalent Units
Derivative security · not the ordinary share price.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Stock Equivalent UnitsGrant or award | Derivative units397$98.83 / derivative unit | $39.24K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units333$98.83 / derivative unit | $32.91K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units318$98.83 / derivative unit | $31.43K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units318$98.83 / derivative unit | $31.43K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units381$98.83 / derivative unit | $37.65K | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Common shares without par valueExercise-price or tax withholding | 52,507$103.99 / share | $5.46M | Sep 23Filed Sep 25 · 2d later | SEC filing |
| VICE PRESIDENT AND CONTROLLER | Common shares without par valueExercise-price or tax withholding | 52$110.36 / share | $5.74K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| VICE PRESIDENT AND CONTROLLER | Common shares without par valueSale | 27$109.54 / share | $2.96K | Sep 2Filed Sep 3 · 1d later | SEC filing |
| EVP AND CFO | Common shares without par valueExercise-price or tax withholding | 388$110.36 / share | $42.82K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| CHAIRMAN AND CEO | Common shares without par valueOption exercise or conversion | 151,869$44.40 / share | $6.74M | Aug 25Filed Aug 27 · 2d later | SEC filing |
| CHAIRMAN AND CEO | Common shares without par valueOption exercise or conversion | 246,963$59.94 / share | $14.8M | Aug 25Filed Aug 27 · 2d later | SEC filing |
| CHAIRMAN AND CEO | Common shares without par valueSale2 trades | 398,832avg $115.85 / share | $46.2M | Aug 25Filed Aug 27 · 2d later | 2 filings
|
| CHAIRMAN AND CEO | Option (right to buy)Option exercise or conversion | Derivative units151,869$44.40 exercise / conversion price | Not a separate purchase | Aug 25Filed Aug 27 · 2d later | SEC filing |
| CHAIRMAN AND CEO | Option (right to buy)Option exercise or conversion | Derivative units246,963$59.94 exercise / conversion price | Not a separate purchase | Aug 25Filed Aug 27 · 2d later | SEC filing |
| EXECUTIVE VICE PRESIDENT | Common shares without par valueSale | 5,850$109.83 / share | $642.51K | Aug 11Filed Aug 13 · 2d later | SEC filing |
| EXECUTIVE VICE PRESIDENT | Common shares without par valueDiscretionary transaction | 12$107.99 / share | $1.3K | Aug 12Filed Aug 13 · 1d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units432$90.74 / derivative unit | $39.2K | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units416$90.74 / derivative unit | $37.75K | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Stock Equivalent UnitsGrant or award | Derivative units363$90.74 / derivative unit | $32.94K | Jun 30Filed Jul 1 · 1d later | SEC filing |
Showing the latest 20 of 49 trades. Show all 49 trades
Abbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a spouse.
Richard W. AllenReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for the member.
Richard Dean Dr McCormickReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a spouse.
Mike KellyReporting House memberAbbott Laboratories Common Stock · Stock
The filing reports a full sale for the member.
Abbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for the member.
Rick LarsenReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Richard Dean Dr McCormickReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Richard Dean Dr McCormickReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for the member.
Gilbert CisnerosReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a spouse.
Richard W. AllenReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a partial sale for a joint account.
Josh GottheimerReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports an exchange for the member.
Laura FriedmanReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Richard Dean Dr McCormickReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Thomas H. Kean JrReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a joint account.
Julie JohnsonReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for the member.
Julia LetlowReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for the member.
Byron DonaldsReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a sale for a spouse.
Byron DonaldsReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a partial sale for a joint account.
Julie JohnsonReporting House memberAbbott Laboratories Common Stock (ABT) · Stock
The filing reports a purchase for the member.
Richard Dean Dr McCormickReporting House memberShowing the latest 25 of 26 disclosed trades. Show all 26 trades
